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Abstract There is ongoing debate regarding the role of neck dissection in differentiated thyroid 
cancer, about its usefulness in elective settings, and the increased costs regarding 
morbidity and operative time. This retrospective study aimed to determine the rate of 
metastases in cervical lymph nodes, to examine the morbidity of this surgery, and to 
assess whether a pattern of distribution of tumor cells concerning neck lymphatic 
compartments exists. The most frequent type of cancer to metastasize was papillary 
cancer, the majority of patients were young with a median of 30 years, predominantly 
females. Differentiated thyroid cancer frequently metastasizes to the central and lateral 
compartments of the neck. The morbidity is minimal in a high-volume center. Radical 
neck dissection is safe and feasible in selected patients with confirmed invaded or 
enlarged lymph nodes due to differentiated thyroid cancer, and postoperative 
complications are minimal if the anatomy is correctly identified and the cases strictly 
selected.   
  












Highlights ✓ Central and lateral neck dissections/ CLND is a feasible option for differentiated thyroid 
cancers, with a low complication rate. 
✓ Berry picking of the enlarged lymph nodes should be avoided, due to the fact that the 
complication rate is similar to CLND and the recurrence rate of malignancy is higher. 
 
Tulin Adrian et al. 
279 
Introduction 
Thyroid cancer has seen a constant increase in 
incidence over the years. It is distributed according to 
cell differentiation into two distinct classes. The first is 
represented by well-differentiated cancers, the most 
frequently encountered being the papillary and follicular 
forms. The second class corresponds to poorly 
differentiated tumors, like medullary and anaplastic 
forms, the latter being associated with fast and 
aggressive evolution (1).     
 Differentiated thyroid cancers generally have a mild 
evolution and good prognosis, the survival of these 
patients 10 years after diagnosis reaching 90%. Papillary 
thyroid cancer, which is one of the most encountered 
types of thyroid cancer, has seen an increase in incidence 
(almost doubled over the last 30 years), largely due to an 
early diagnosis of subclinical cases (through the 
emergence of new techniques of diagnosis and early 
access to specialized medical care) (2, 3).  
 Lymphatic metastasizing is frequent and is 
diagnosed in up to 50% of the cases; there are 
controversies about the prognostic value of these 
metastases, which do not seem to influence survival. 
Subclinical metastases are encountered in a large 
number of patients, and do not affect postoperative 
survival. A frequent site of metastasis is the central 
compartment of the neck, which contains the VI-th and 
VII-th lymphatic stations of the neck (4-6). 
 The European Treatment Guidelines (ETA) 
recommend systematically performing dissection of the 
neck compartments which contain enlarged lymph 
nodes, identified either preoperatively (with the help of 
ultrasound) or intraoperatively (during extemporaneous 
examination). This recommendation rests on the fact 
that young patients who are often diagnosed with 
aggressive forms of thyroid cancer have a benefit 
regarding overall survival, while for the other patients 
recurrence seems to be reduced when lymphatic 
dissection is performed (7, 8).  
 According to the European Guidelines, such 
surgical options are recommended only when enlarged 
or invasive nodules are present. In the USA, this 
procedure (routine lymph dissection of the central neck 
compartment) is not yet included in treatment guidelines 
(being currently under discussion), due to the high rate 
of invasion at this level at the time of diagnosis (9, 10). 
There is legitimate hesitation to adopt this technique in 
elective conditions, due to the high postoperative 
morbidity. Possible complications include recurrent 
laryngeal nerve injury (which is constantly located in the 
tracheoesophageal groove, where the lymphatic tissue 
needs to be dissected and removed) and postoperative 
hypoparathyroidism. Between 3% and 6% of patients 
undergoing central compartment lymph node dissection 
remain with postoperative hypoparathyroidism and/ or 
temporal dysphonia (11).     
 The scope of this study was to evaluate (based on 
our clinic database) the rate of postoperative 
complications (hypocalcemia, recurrent laryngeal nerve 
injury) resulting after central and lateral neck dissections 
(CLND), and the rate/ path of metastasis encountered in 
the case of local lymph nodes. 
Materials and Methods 
The study was designed as an observational and 
retrospective analysis, being performed on 88 patients 
with thyroid disease who were operated (irrespective of 
the operative indication) between January 2014 and July 
2018 in the Clinic of General Surgery of Emergency 
Hospital `Prof. Dr. Agrippa Ionescu` Bucharest. We 
enrolled in this trial 44 patients who underwent total 
thyroidectomy and 44 who underwent total 
thyroidectomy with CNLD. All patients were referred to 
the surgical department after evaluation by a 
multidisciplinary team, coordinated by the 
endocrinologist. Informed consent was signed by 
patients so as to be able to collect and use the data. The 
hospital ethical committee approved the study, data 
included in analysis being related especially to the 
patients' age, gender, and histopathological report. 
Statistical analysis was done using SPSS V20. Patients 
were selected for CLND if enlarged lymph nodes were 
identified at clinical examination, through 
ultrasonography, or during extemporaneous examina-
tion. The lymph dissection was performed only on the 
side of the neck where the enlarged lymph nodes were 
identified (Picture 1). 
 
Figure 1. Shows the main vessels of the neck after 
lymphatic dissection, starting from the outside: the 
internal jugular vein, common carotid artery, and the 
vagus nerve between them. We did not use a neuro-
locator device to identify the recurrent laryngeal 
nerves; rather they were identified by careful 
dissection in the esophagotracheal groove (Figure 2). 
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Figure 2. The recurrent laryngeal nerve 
identified and protected at the inferior pole of 
the left thyroid lobe. 
Results   
The majority of patients were females, with a 4:1 
(female to male) gender ratio. Mean age of the study 
group was 50 years, ranging from 19 to 73, the standard 
deviation being 13,4. Mean age of the patients with 
CLND was 39 years. 
The histopathological report showed that the 
median tumour size which was associated with 
lymphatic dissemination was 18,2 mm. Regarding 
cellular type, the majority of tumors were papillary 
(63.63%: n=56), followed by follicular (15.9%: n=14), 
medullary (9.9%: n=8), and anaplastic (11.36% n=10). 
Multifocality in the thyroid gland was identified in 
35.22% (n=31) of the cases with invaded locoregional 
nodes. The average excision of each intervention was 15 
lymph nodes, of which about 6 presented a tumoral 
infiltration. A local invasion through the thyroid capsule 
into adjacent structures (which corresponds to T4 
tumours) was observed only in cases of anaplastic 
tumours. 
10.22% (n=9) of the patients without CLND and 
12.5% (n=11) of the patients who underwent CLND had 
postoperative complications. The Pearson chi-square for 
this association had a value of 0.20, p=0.61.  
In the two groups (thyroidectomy alone vs. 
thyroidectomy plus CLND), transient hypocalcemia was 
present in 5.68% (n=5) vs. 7.95% (n=7), transient 
recurrent nerve paresis in 2.27% (n=2) vs. 2.27% (n=2), 
postoperative neck hematoma in 3.4% (n=3) vs. 1.13% 
(n=1). No correlation was found between any type of 
complication and the two types of surgical procedures. 
Pearson Chi-Square value was 0.681, p= 0.8. 
Metastasis to the lymph nodes was identified more 
frequently in patients with extracapsular invasion than 
in patients without invasion. The central compartment 
with the levels VI (peri-thyroidal paralaryngeal, 
paratracheal, pretracheal and prelaryngeal nodes) and 
VII (upper anterior mediastinal lymph nodes) was noted 
as the most frequently involved in the lymphatic 
dissemination of the tumour cells (n=8), followed by the 
lateral neck compartment (n=4), and superior 
mediastinum (n=2). Levels I and V presented the lowest 
rate of metastasis. Contralateral lymph nodes could not 
be evaluated due to the fact that the authors generally 
did not undertake contralateral neck dissection in 
elective settings. 
 
Table 1. Tumor spread  




























Total 44 100,0 
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Discussions   
Neck dissection plays an essential role in surgical 
management of head and neck cancer patients. In the 
studied sample, the CLND was performed as elective 
procedure, that is only in cases of clinically enlarged 
lymph nodes (that were identified preoperatively), or in 
cases of lymph nodes identified during the 
intraoperative extemporaneous evaluation (and 
confirmed as being invaded by tumoral cells). This 
decision was undertaken due to the risk of complications 
related to the recurrent laryngeal nerve or 
hypoparathyroidism. Such complications can occur in 
up to 6% of the patients, as demonstrated by multiple 
clinical trials, which recommend that radical dissection 
of the neck should be limited in thyroid cancer only to 
compartments that present enlarged lymph-nodes (12, 
13). Diagnostic procedures used for detection of the 
lymph nodes were represented by clinical and 
ultrasound examinations, the latter playing a crucial but 
not definitive role, as they can give false negative results 
due to its sensitivity and specificity (14). 
Other authors recommend prophylactic CLND in 
patients with cN0 not only for T3 or T4 tumours, but 
also for tumours larger than 1 cm. This tactical decision 
is argued regarding small tumors by the fact that the 
presence of lymph node metastases can change 
postoperative treatment regardless of the location of the 
primary tumor. As an example of tactical decision-
making, small (pT1) tumours limited to the thyroid 
gland/capsule but with lymphatic metastasis receive 
radioiodine therapy, while larger (pT2) tumours without 
lymph node metastasis do not (15, 16). Due to the 
extensive dissection and anatomical implications of 
CLND, some surgeons in the past have advocated for 
“berry picking” resections aimed at removing only 
macroscopically enlarged nodes (17, 18). We do not 
fully agree with this technique, since these “berry 
picking” surgeries are associated with high recurrence 
rates (which in turn require reoperation that is in often 
associated with a higher complication rate due to local 
fibrosis). As noted by Munacchio et al., the complication 
rate in functional neck dissections is no higher than 
those identified in berry picking surgeries (19). 
CLND is associated with an increased rate of 
transient hypocalcemia when compared to simple total 
thyroidectomy; this view point is consistent with our 
data, where the incidence of transient hypocalcemia in 
thyroidectomy group was 8% while in the CLND group 
it approached 10%. This oscillation is probably due to 
thyroid gland anatomy, especially the inferior region 
that can easily be extracted with the lymph nodes from 
the central compartment. Vascular compromise as a 
source of blood comes from the same inferior region/ 
thyroid arteries, located in an extensive dissected area. 
When the parathyroid gland was recognized, after 
resection, it was transplanted by injection of a 
suspension solution of parathyroid in the 
sternocleidomastoid muscle. The utility of the procedure 
could not be evaluated, due to the fact that in no cases 
were all of the four glands were resected. This aspect is 
related to the observation that parathyroid function 
correlates with the number of parathyroid glands that 
remain. 
Postoperative dosage of calcium and parathyroid 
hormone/ PTH levels should be done in elective settings 
when an extended lateral neck dissection is performed, 
to be able to rapidly initiate treatment for hypocalcemia 
and shield the patient from the associated morbidities. 
When available, intraoperative dosages of PTH levels 
offer the best image over the functionality of the 
parathyroid glands (20, 21). 
Regarding the rate of the recurrent laryngeal nerve 
injury, we had an incidence of 6% in CLND, 
significantly higher than that related to total 
thyroidectomy, which was about 4%. As noted before, 
this rate increases due to the extensive dissection of the 
lymph nodes, especially those of the central 
compartment, which frequently wrap around the 
recurrent laryngeal nerve. In addition, some tumours 
increase the overall size of the thyroid gland and invade 
the surrounding structures with subsequent local 
retraction.  
In such cases, familiarity of the local anatomy, with 
slow and careful dissection, should be the basic option, 
with the possibility of using the neurolocator when there 
are doubts, as the use of a neurolocator can reduce the 
incidence of nerve damage when tissue deformity is 
present (22). All of our procedures involved central and 
lateral neck dissection, including the posterior triangle 
which can be associated with spinal accessory nerve 
damage. Therefore, great care must be taken to avoid 
nerve damage. A helpful tip is to set the markers along 
the nerve course (which projects superficially by 
connecting the mandible angle and the mastoid process), 
addressing this line in middle. The lower course of this 
line should be avoided, as it generally represents the 
assumed path of the spinal accessory nerve (23).  
Patients with large tumours and extracapsular 
invasion are often associated with lymph node 
metastasis, this observation being also confirmed by 
Ortiz S et al. (24). The histopathology reports revealed, 
especially for papillary cancer type, that dissemination 
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of the tumoral cells to the lymph nodes from the central 
and lateral compartments was frequently found. Non-
invaded nodes or those with limited invasion to only one 
lymph node was rarely observed, similar to literature 
data (25). Elective dissection of the contralateral lymph 
nodes was avoided, because it is rarely involved in 
metastasis of differentiated thyroid cancer (26).     
Study limits. The study has the limits of a 
retrospective investigation: the researchers could not 
control the exposure or outcome assessment or the 
accuracy of recordkeeping, thus making it subject to 
biases. Also, the temporal relationship regarding the 
evolution of the subjects was difficult to evaluate. Even 
if the question of making a radical neck dissection in 
thyroid cancer is still under debate/ development, the 
utility of this procedure has been demonstrated for some 
patients. In contrast, postoperative complication rates, 
such as hypocalcemia and intermittent/ permanent 
recurrent laryngeal nerve paralysis, are more often 
encountered in thyroidectomy with CLND dissection 
that occurs only in thyroidectomy. For these reasons, the 
authors recommend special attention to the dissection 
procedure and a thorough knowledge of the local 
anatomy. Large prospective randomized trials are 
needed to demonstrate the utility of elective neck 
dissection of the central compartments (taking into 
account the risk-benefit ratio), due to the significant 
morbidity associated with this procedure (27, 28). 
Conclusions 
CLND is a feasible option with a low complication 
rate for differentiated thyroid cancers when the local 
anatomy is clearly understood. Still debatable is whether 
to use it in elective settings, such that large prospective 
randomised trials are required in the future to 
demonstrate its benefits. Compared to thyroidectomy 
alone, there is an increased rate of hypoparathyroidism 
and recurrent laryngeal nerve damage in thyroidectomy 
associating central and lateral neck dissections. Berry 
picking of the enlarged lymph nodes should be avoided, 
due to the fact that the complication rate is similar to 
CLND and the recurrence rate of malignancy is higher.  
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